Clinical and Pathologic Complete Response to Gefitinib in a Patient with SqCLC Harboring EGFR p.E746_S752delinsV Mutation

Clinical and Pathologic Complete Response to Gefitinib in a Patient with SqCLC Harboring EGFR p.E746_S752delinsV Mutation

Weitao Zhuang,1,2 Chao Zhang,3 Yong Tang,1 Dan Tian,1 Zihua Lan,1,2 Cheng Zeng,1 Guibin Qiao1 1Department of Thoracic Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People’s Republic of China; 2Shantou University Medical College, Shantou, 5...

Full description

Bibliographic Details
Main Authors: Zhuang W, Zhang C, Tang Y, Tian D, Lan Z, Zeng C, Qiao G
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:OncoTargets and Therapy
Subjects:
epidermal growth factor receptor
squamous cell lung cancer
tyrosine kinase inhibitor
next generation sequencing
egfr p.e746_s752delinsv mutation
Online Access:https://www.dovepress.com/clinical-and-pathologic-complete-response-to-gefitinib-in-a-patient-wi-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/clinical-and-pathologic-complete-response-to-gefitinib-in-a-patient-wi-peer-reviewed-fulltext-article-OTT

Similar Items